(Q53965155)

23 May 2018

title

Fluvastatin and tissue factor pathway inhibitor in type IIA and IIB hyperlipidemia and in acute myocardial infarction. (English)

1 reference

23 May 2018

1 reference

myocardial infarction

1 reference

4

1 reference

23 May 2018

author name string

Lorena M

1

1 reference

23 May 2018

Perolini S

2

1 reference

23 May 2018

Casazza F

3

1 reference

23 May 2018

Cimminiello C

5

1 reference

23 May 2018

publication date

1 August 1997

1 reference

23 May 2018

published in

Thrombosis Research

1 reference

23 May 2018

volume

87

1 reference

23 May 2018

issue

4

1 reference

23 May 2018

page(s)

397-403

1 reference

23 May 2018

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Factor VII and extrinsic pathway inhibitor in acute coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

Lipoprotein fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900143-6

7 January 2021

10.1016/S0049-3848(97)00143-6

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018